Literature DB >> 10557270

Glycosylation differences between the normal and pathogenic prion protein isoforms.

P M Rudd1, T Endo, C Colominas, D Groth, S F Wheeler, D J Harvey, M R Wormald, H Serban, S B Prusiner, A Kobata, R A Dwek.   

Abstract

Prion protein consists of an ensemble of glycosylated variants or glycoforms. The enzymes that direct oligosaccharide processing, and hence control the glycan profile for any given glycoprotein, are often exquisitely sensitive to other events taking place within the cell in which the glycoprotein is expressed. Alterations in the populations of sugars attached to proteins can reflect changes caused, for example, by developmental processes or by disease. Here we report that normal (PrP(C)) and pathogenic (PrP(Sc)) prion proteins (PrP) from Syrian hamsters contain the same set of at least 52 bi-, tri-, and tetraantennary N-linked oligosaccharides, although the relative proportions of individual glycans differ. This conservation of structure suggests that the conversion of PrP(C) into PrP(Sc) is not confined to a subset of PrPs that contain specific sugars. Compared with PrP(C), PrP(Sc) contains decreased levels of glycans with bisecting GlcNAc residues and increased levels of tri- and tetraantennary sugars. This change is consistent with a decrease in the activity of N-acetylglucosaminyltransferase III (GnTIII) toward PrP(C) in cells where PrP(Sc) is formed and argues that, in at least some cells forming PrP(Sc), the glycosylation machinery has been perturbed. The reduction in GnTIII activity is intriguing both with respect to the pathogenesis of the prion disease and the replication pathway for prions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557270      PMCID: PMC23897          DOI: 10.1073/pnas.96.23.13044

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Prion protein conformation in a patient with sporadic fatal insomnia.

Authors:  J A Mastrianni; R Nixon; R Layzer; G C Telling; D Han; S J DeArmond; S B Prusiner
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

Review 2.  Prion diseases and the BSE crisis.

Authors:  S B Prusiner
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

3.  Separation and properties of cellular and scrapie prion proteins.

Authors:  R K Meyer; M P McKinley; K A Bowman; M B Braunfeld; R A Barry; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions.

Authors:  E Stimson; J Hope; A Chong; A L Burlingame
Journal:  Biochemistry       Date:  1999-04-13       Impact factor: 3.162

5.  Purification and structural studies of a major scrapie prion protein.

Authors:  S B Prusiner; D F Groth; D C Bolton; S B Kent; L E Hood
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

6.  Replication of the scrapie agent in hamster brain precedes neuronal vacuolation.

Authors:  J R Baringer; K A Bowman; S B Prusiner
Journal:  J Neuropathol Exp Neurol       Date:  1983-09       Impact factor: 3.685

7.  Asparagine-linked glycosylation of the scrapie and cellular prion proteins.

Authors:  T Haraguchi; S Fisher; S Olofsson; T Endo; D Groth; A Tarentino; D R Borchelt; D Teplow; L Hood; A Burlingame
Journal:  Arch Biochem Biophys       Date:  1989-10       Impact factor: 4.013

8.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.

Authors:  R B Parekh; R A Dwek; B J Sutton; D L Fernandes; A Leung; D Stanworth; T W Rademacher; T Mizuochi; T Taniguchi; K Matsuta
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

9.  Reduced B-cell galactosyltransferase activity in rheumatoid arthritis.

Authors:  J S Axford; L Mackenzie; P M Lydyard; F C Hay; D A Isenberg; I M Roitt
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

10.  Scrapie PrP 27-30 is a sialoglycoprotein.

Authors:  D C Bolton; R K Meyer; S B Prusiner
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

View more
  79 in total

1.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Distance of sequons to the C-terminus influences the cellular N-glycosylation of the prion protein.

Authors:  Adrian R Walmsley; Nigel M Hooper
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

4.  Proteolytic processing and glycosylation influence formation of porcine prion protein complexes.

Authors:  Krzysztof Nieznanski; Marcin Rutkowski; Magdalena Dominik; Dariusz Stepkowski
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

5.  Simulations of membrane-bound diglycosylated human prion protein reveal potential protective mechanisms against misfolding.

Authors:  Chin Jung Cheng; Heidi Koldsø; Marc W Van der Kamp; Birgit Schiøtt; Valerie Daggett
Journal:  J Neurochem       Date:  2017-05-22       Impact factor: 5.372

6.  Normal cellular prion protein is a ligand of selectins: binding requires Le(X) but is inhibited by sLe(X).

Authors:  Chaoyang Li; Poki Wong; Tao Pan; Fan Xiao; Shaoman Yin; Binggong Chang; Shin-Chung Kang; James Ironside; Man-Sun Sy
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

7.  One O-linked sugar can affect the coil-to-beta structural transition of the prion peptide.

Authors:  Pei-Yeh Chen; Chun-Cheng Lin; Yin-Ting Chang; Su-Ching Lin; Sunney I Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

8.  Lipopolysaccharide induced conversion of recombinant prion protein.

Authors:  Fozia Saleem; Trent C Bjorndahl; Carol L Ladner; Rolando Perez-Pineiro; Burim N Ametaj; David S Wishart
Journal:  Prion       Date:  2014-05-12       Impact factor: 3.931

9.  PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.

Authors:  Franc Llorens; Belén Ansoleaga; Paula Garcia-Esparcia; Saima Zafar; Oriol Grau-Rivera; Irene López-González; Rosi Blanco; Margarita Carmona; Jordi Yagüe; Carlos Nos; José Antonio Del Río; Ellen Gelpí; Inga Zerr; Isidre Ferrer
Journal:  Prion       Date:  2013-09-18       Impact factor: 3.931

10.  Novel antibody-lectin enzyme-linked immunosorbent assay that distinguishes prion proteins in sporadic and variant cases of Creutzfeldt-Jakob disease.

Authors:  Tao Pan; Ruliang Li; Boon-Seng Wong; Shin-Chung Kang; James Ironside; Man-Sun Sy
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.